Immunotherapy for Multiple Myeloma

Project title: Immunotherapy for Multiple Myeloma: A New Generation of Chimeric Antigen Receptors and Immune Checkpoint Blockad (IMS_TRG_22_01)

Funding agency: Sociedad Internacional de Mieloma

Start and end date: 01/03/2022 – 09/08/2023